Browsing: GEPNETs

Treatments

Minimal Risk of Liver Failure Identified With Theranostics in GEP-NETs

By NewsCancerApril 11, 20260

Treatment with peptide receptor radionuclide therapy (PRRT) did not result in the development of liver failure during the treatment of…

Support

By NewsCancerMarch 2, 20260

The FDA granted tentative approval to PNT2003 (lutetium Lu 177 dotatate), a radioequivalent version of lutetium Lu 177 dotatate (Lutathera),…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.